Literature DB >> 18584194

Prevalence of adverse drug combinations in a large post-mortem toxicology database.

Terhi Launiainen1, Erkki Vuori, Ilkka Ojanperä.   

Abstract

The prevalence of important adverse drug combinations was studied among the 37,367 cases included in the Finnish post-mortem toxicology database during 2000-2006. The new SFINX interaction database (Swedish, Finnish, INteraction X-referencing) was utilised to identify adverse drug combinations. Consequently, the 24 drugs chosen for the study generated 96 two-compound combinations possessing potentially severe interactions. The total number of hits for the combinations found in the post-mortem database was 267, which accounts for approximately 0.71% of all cases. The potential role of adverse drug interaction (ADI) in these cases was evaluated from the background information and death certificate. The possible ADI cases comprised 23% of all hits and 0.17% of all cases analysed. In cases with a pharmacodynamic mechanism, the most prominent combinations were medicines causing serotonin syndrome or a beta(1)-blocker with verapamil or diltiazem. In cases with a pharmacokinetic mechanism, half of the cases involved digoxin in combination with verapamil. In one third of the possible ADI cases, a forensic pathologist had noted the studied compounds as an underlying or contributing cause of death, although the agents' specific role in ADIs was rarely recognised.

Entities:  

Mesh:

Year:  2008        PMID: 18584194     DOI: 10.1007/s00414-008-0261-3

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  34 in total

1.  Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

Authors:  Nicholas A Buckley; Peter R McManus
Journal:  BMJ       Date:  2002-12-07

2.  Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000.

Authors:  Survjit Cheeta; Fabrizio Schifano; Adenekan Oyefeso; Lucy Webb; A Hamid Ghodse
Journal:  Br J Psychiatry       Date:  2004-01       Impact factor: 9.319

3.  Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.

Authors:  Gudrun Høiseth; Jørgen G Bramness; Asbjørg S Christophersen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

Review 4.  Requirements for bioanalytical procedures in postmortem toxicology.

Authors:  Olaf H Drummer
Journal:  Anal Bioanal Chem       Date:  2007-03-23       Impact factor: 4.142

5.  Drug-drug interactions - a preventable patient safety issue?

Authors:  Johanna Strandell; Andrew Bate; Marie Lindquist; I Ralph Edwards
Journal:  Br J Clin Pharmacol       Date:  2007-07-17       Impact factor: 4.335

6.  Death following ingestion of MDMA (ecstasy) and moclobemide.

Authors:  Erkki Vuori; John A Henry; Ilkka Ojanperä; Raija Nieminen; Taru Savolainen; Pia Wahlsten; Matti Jäntti
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

Review 7.  Serotonin toxicity: a practical approach to diagnosis and treatment.

Authors:  Geoffrey K Isbister; Nicholas A Buckley; Ian M Whyte
Journal:  Med J Aust       Date:  2007-09-17       Impact factor: 7.738

8.  Alcohol and benzodiazepines in fatal poisonings.

Authors:  Anna Koski; Ilkka Ojanperä; Erkki Vuori
Journal:  Alcohol Clin Exp Res       Date:  2002-07       Impact factor: 3.455

9.  Alcohol and drugs in suicides.

Authors:  A Ohberg; E Vuori; I Ojanperä; J Lonngvist
Journal:  Br J Psychiatry       Date:  1996-07       Impact factor: 9.319

10.  Six deaths linked to concomitant use of buprenorphine and benzodiazepines.

Authors:  M Reynaud; G Petit; D Potard; P Courty
Journal:  Addiction       Date:  1998-09       Impact factor: 6.526

View more
  7 in total

1.  Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.

Authors:  Terhi Launiainen; Antti Sajantila; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2009-09-25       Impact factor: 2.953

2.  Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.

Authors:  Terhi Launiainen; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2010-04-30       Impact factor: 2.686

3.  A limited number of prescribed drugs account for the great majority of drug-drug interactions.

Authors:  Johan Holm; Birgit Eiermann; Erik Eliasson; Buster Mannheimer
Journal:  Eur J Clin Pharmacol       Date:  2014-09-06       Impact factor: 2.953

4.  Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning.

Authors:  Margareeta Häkkinen; Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2011-09-17       Impact factor: 2.953

5.  Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users.

Authors:  Anu M Neuvonen; Jukka U Palo; Antti Sajantila
Journal:  Int J Legal Med       Date:  2011-02-11       Impact factor: 2.686

6.  ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.

Authors:  L Karlsson; H Green; A L Zackrisson; F Bengtsson; I Jakobsen Falk; B Carlsson; J Ahlner; F C Kugelberg
Journal:  Int J Legal Med       Date:  2013-03-21       Impact factor: 2.686

7.  Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma.

Authors:  Terhi Launiainen; Ilkka Ojanperä
Journal:  Drug Test Anal       Date:  2013-07-23       Impact factor: 3.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.